Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppressi...
For treatment of acute myeloid leukaemia.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.